Martha Sedegah

Martha Sedegah serves as a key procurement professional at the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical research and field-deployable medical technologies. She manages the acquisition lifecycle for high-priority R&D contracts focused on infectious disease diagnostics, laboratory analytics, and operational medical systems tailored for austere environments. Her work directly enables the center’s strategic objectives by ensuring timely access to cutting-edge scientific capabilities, bridging the gap between laboratory innovation and frontline military medical readiness. She typically handles complex, performance-based solicitations requiring technical rigor and compliance with federal research procurement standards. Sedegah maintains a primary contracting relationship with REES SCIENTIFIC CORPORATION, a trusted vendor with demonstrated expertise in developing diagnostic tools and biomedical instrumentation for military applications. Her procurement pattern reflects a preference for established, technically capable contractors with proven track records in defense-relevant research, indicating a reliance on specialized firms capable of meeting stringent performance and validation requirements. While she engages with a narrow set of vendors, her collaborations are characterized by sustained, mission-aligned partnerships rather than transactional sourcing. Sedegah’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a deliberate focus on technical merit and capability over socioeconomic preferences, prioritizing mission-critical outcomes and the availability of specialized expertise over programmatic set-asides such as 8(a), HUBZone, or SDVOSB. Her approach underscores the unique demands of biomedical R&D, where niche capabilities often reside in a limited pool of qualified firms. Her primary procurement focus is on NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences—encompassing contract types such as CRADAs, BPA’s, and other research service agreements. She procures advanced diagnostic platforms, pathogen detection systems, and analytical instrumentation designed for rapid deployment in expeditionary settings, demonstrating deep familiarity with the technical and regulatory frameworks governing defense biomedical innovation.